The one-eye trial and fellow eye response to prostaglandin analogues

被引:13
作者
Dayanir, Volkan [1 ]
Cakmak, Harun [1 ]
Berkit, Ilker [1 ]
机构
[1] Adnan Menderes Univ, Sch Med, Dept Ophthalmol, Aydin, Turkey
关键词
fellow eye; intraocular pressure; office hours; one-eye trial; prostaglandin analogues;
D O I
10.1111/j.1442-9071.2008.01698.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: To determine if the intraocular pressure (IOP) reduction in one-eye trial correlates with the IOP reduction in the fellow eye when IOP variability during office hours is taken into account. Methods: This retrospective observational case series includes 50 high tension (primary open-angle glaucoma, exfoliative glaucoma and ocular hypertension; Group 1) and 21 normal tension (Group 2) glaucoma patients. Charts of bilateral open-angle glaucoma patients at Glaucoma Unit, School of Medicine, Adnan Menderes University who had pretreatment baseline office IOP measurements at 9:30, 11:30 and 15:30; were put on a one-eye trial with prostaglandin analogues, and then subsequently received the same medication in the fellow eye were reviewed. Pretreatment baseline office IOP measurements and reductions in the first and second eyes were compared to determine variability and correlation, respectively. Results: Both groups showed significant variability in pretreatment baseline office IOP measurements. Peak IOP level was before noon in at least 70% of eyes in Group 1, 50% in Group 2. IOP dropped a mean of 8.8 +/- 4.8 mmHg (34%, P = < 0.0001) in Group 1 and 4.9 +/- 2.4 mmHg (30%, P = < 0.0001) in Group 2 during the one-eye trial. Following bilateral use of the medication a mean drop of 7.5 +/- 4.0 mmHg (31%, P = < 0.0001) in Group 1 and 2.9 +/- 1.9 mmHg (18%, P = < 0.0001) in Group 2 were obtained. The IOP reduction between fellow-eye pairs were significantly correlated in Group 1 (r = 0.541, P = < 0.0001) but not Group 2 (r = -0.310, P = 0.171). Conclusions: One-eye trial is a feasible method to determine the effectiveness of prostaglandin analogues and to predict the amount of IOP reduction in the fellow eye in patients with high tension glaucoma.
引用
收藏
页码:136 / 141
页数:6
相关论文
共 21 条
[1]  
American Academy of Ophthalmology, 2003, PRIM OP ANGL GLAUC
[2]  
Asrani S, 2000, J GLAUCOMA, V9, P134
[3]   Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP -: A 3-month clinical trial [J].
Brandt, JD ;
VanDenburgh, AM ;
Chen, K ;
Whitcup, SM .
OPHTHALMOLOGY, 2001, 108 (06) :1023-1031
[4]   DIURNAL INTRAOCULAR-PRESSURE VARIATIONS - AN ANALYSIS OF 690 DIURNAL CURVES [J].
DAVID, R ;
ZANGWILL, L ;
BRISCOE, D ;
DAGAN, M ;
YAGEV, R ;
YASSUR, Y .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1992, 76 (05) :280-283
[5]  
Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714
[6]   The effect of latanoprost on intraocular pressure during 2 years of treatment [J].
Hedman, K ;
Watson, PG ;
Alm, A .
SURVEY OF OPHTHALMOLOGY, 2002, 47 :S65-S76
[7]   Reduction of intraocular pressure and glaucoma progression - Results from the early manifest glaucoma trial [J].
Heijl, A ;
Leske, MC ;
Bengtsson, B ;
Hyman, L ;
Bengtsson, B ;
Hussein, M .
ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (10) :1268-1279
[8]   24-hour monitoring of intraocular pressure in glaucoma management: A retrospective review [J].
Hughes, E ;
Spry, P ;
Diamond, J .
JOURNAL OF GLAUCOMA, 2003, 12 (03) :232-236
[9]  
Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701
[10]  
Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48